Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing
Transaction expected to significantly advance commercial readiness of NanoSynex's innovative diagnostics technology platform focused on the $30+ Billion global infectious disease testing
Qualigen Therapeutics Inc (NASDAQ:QLGN) has agreed to acquire a majority stake in NanoSynex Ltd, an Israeli-based developer of next-generation diagnostics technology. NanoSynex’s…
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for Nanocyn hospital-grade disinfectant in the U.S.